Management strategies in alcoholic liver disease

@article{Tilg2007ManagementSI,
  title={Management strategies in alcoholic liver disease},
  author={Herbert Tilg and Christopher Paul Day},
  journal={Nature Clinical Practice Gastroenterology \&Hepatology},
  year={2007},
  volume={4},
  pages={24-34}
}
  • H. Tilg, C. Day
  • Published 2007
  • Medicine
  • Nature Clinical Practice Gastroenterology &Hepatology
Alcoholic liver disease (ALD) and its complications is still one of the most frequent causes of death in the Western world. Treatment modalities for both alcoholic steatohepatitis (ASH; the major inflammatory complication of ALD) and alcoholic liver cirrhosis are insufficient. Severe ASH is associated with a high mortality; although glucocorticoid treatment has been reported to improve survival, meta-analyses of clinical trials performed to date have failed to show a convincing benefit of such… 
Current concepts in the treatment of alcoholic liver disease
TLDR
From the study of antioxidant therapy it appears that, antioxidant therapy is more beneficial in alcoholic hepatitis than in alcoholic cirrhosis, Consequently, liver transplantation remains the ultimate option for selected patients alcoholic Cirrhosis.
Alcohol and the liver
TLDR
Much of the pathogenesis of ALD has been identified and headway has been made in predicting its prognosis, however, much remains to be done to elucidate the molecular genetics of the risk of developing ALD and in formulating safe, effective therapies for alcoholic hepatitis.
Alcohol and the liver
TLDR
Much of the pathogenesis of ALD has been identified and headway has been made in predicting its prognosis, however, much remains to be done to elucidate the molecular genetics of the risk of developing ALD and in formulating safe, effective therapies for alcoholic hepatitis.
Understanding and treating patients with alcoholic cirrhosis: an update.
TLDR
Information available suggests the need of a multimodal approach in the clinical management of patients with alcoholic cirrhosis, including more attention to co-factors that may increase risk of ALD.
Alcoholic liver disease: a modern look at diagnosis and treatment
TLDR
It has been shown that therapy with Remaxol®, the original polyionic succinatemethionine complex based on succinic acid is an effective method of treating alcoholic liver disease.
New concepts in the pathogenesis of alcoholic liver disease
  • E. Albano
  • Medicine
    Expert review of gastroenterology & hepatology
  • 2008
TLDR
The most recent findings on the mechanisms by which alcohol abuse causes hepatic steatosis and steatohepatitis are discussed, and now it contributes to the progression of fibrosis.
Successful Ayurvedic Management of Alcoholic Liver Disease: A Case Report
TLDR
A case report of a diagnosed case of Alcoholic liver disease, presented with main symptoms: nausea, vomiting, swelling in bilateral foot, weakness in the body, reduced appetite, gradually weight reduction and semisolid stool with frequency of 6-7 times/ day, there was found significant recovery of the patient subjectively as well as objectively.
Pharmacotherapy for alcoholic patients with alcoholic liver disease.
TLDR
Although various treatments have been investigated for ALD in patients with alcoholism, complete abstinence from alcohol is currently the only recommended form of hepatoprotection for the entire spectrum of ALD diagnoses.
Adipose tissue-liver axis in alcoholic liver disease.
TLDR
The mechanisms whereby chronic alcohol exposure contributed to adipose tissue dysfunction, including cell death, inflammation and insulin resistance are discussed, as well as the recent research progress in the field with a focus on how abnormal methionine metabolism in adipOSE tissue contributes to adiposes tissue dysfunction and liver damage.
Alcohol and the liver
  • A. Reuben
  • Medicine
    Current opinion in gastroenterology
  • 2008
TLDR
Basic and clinical research into the mechanisms of alcoholic liver disease is making headway, but has yet to produce safe and effective therapies for alcoholic hepatitis and for reversing cirrhosis.
...
...

References

SHOWING 1-10 OF 82 REFERENCES
Glucocorticosteroids Are Not Effective in Alcoholic Hepatitis
TLDR
The evidence does not support the contention that glucocorticosteroids should be recommended for the treatment of patients with alcoholic hepatitis, including those with hepatic encephalopathy, and meta-analysis based on fixed-effects methods is not valid.
A randomized trial of prednisolone in patients with severe alcoholic hepatitis.
TLDR
Treatment with prednisolone improves the short-term survival of patients with severe biopsy-proved alcoholic hepatitis and persisted after stratification according to center and the presence of encephalopathy, and after adjustment for prognostic factors in a proportional-hazards model.
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.
TLDR
Treatment with PTX improves short-term survival in patients with severe alcoholic hepatitis and appears to be related to a significant decrease in the risk of developing hepatorenal syndrome.
...
...